Is Piriton (Chlorpheniramine) available in an intravenous (IV) form?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Piriton (Chlorpheniramine) IV Availability

Yes, Piriton (chlorpheniramine) is available in intravenous form and can be administered IV or IM in acute settings, particularly for anaphylactic reactions.

Clinical Formulations and Routes

Chlorpheniramine is available for parenteral administration via both intravenous and intramuscular routes. 1 The drug can be given IV slowly or IM, with specific dosing protocols established for emergency situations. 2

  • IV/IM administration is documented and widely used in clinical practice, particularly in anaesthesia and critical care settings. 1
  • Subcutaneous routes have also been documented, though less commonly used. 2
  • The parenteral formulation is distinct from the more common oral tablets, capsules, and syrups. 2

Dosing for Anaphylaxis (Secondary Management)

The Association of Anaesthetists of Great Britain and Ireland provides clear IV dosing guidelines for chlorpheniramine in anaphylactic reactions:

Adult Dosing

  • 10 mg IV (or IM) slowly for patients >12 years. 1

Pediatric Dosing

  • 6-12 years: 5 mg IV or IM slowly. 1
  • 6 months to 6 years: 2.5 mg IV or IM slowly. 1
  • <6 months: 250 µg/kg IV or IM slowly. 1

Clinical Context and Timing

  • Chlorpheniramine IV is administered as secondary management in anaphylaxis, after initial stabilization with adrenaline and fluid resuscitation. 1
  • It should be given alongside hydrocortisone 200 mg IV (adult dose) as part of the standard anaphylaxis protocol. 1
  • The IV route allows for rapid onset in acute allergic emergencies where oral administration is not feasible. 1

Important Caveats

  • Administer IV chlorpheniramine slowly to minimize adverse effects. 1
  • The parenteral route bypasses the significant first-pass metabolism that limits oral bioavailability (only 25-45% reaches systemic circulation orally). 2, 3, 4
  • IV access must be established before administration; if unavailable, the IM route is an acceptable alternative. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.